| 摘要 |
Disclosed are vaccine compositions comprising open reading frame (ORF) 2, ORF 5 and ORF 7 nucleic acid of EAV, and vectors comprising said ORFs. Also disclosed are methods of using the ORFs and vectors in the manufacture of a medicament for the prevention and treatment of EAV infections.
|
